This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant proteinproduction.
To set the stage for this case, we need to go back to March 2020 , when a new definition of “biological product” threw the world of proteinproducts into a tizzy. And, like it has before , the District Court of D.C. recently grappled with this very question in Ipsen v.
My last stop at Arrakis Therapeutics is with a company targeting RNA with smallmolecules. I was enticed by Arrakis’ founder Jen Petter to serve in one more operational role, leading the research group at Arrakis as the company launched as one of the first biotechs to target RNA with drug-like smallmolecules.
Premature stop codons are point mutations that disrupt protein synthesis from messenger RNA. As a consequence, patients with premature stop codon diseases have reduced or eliminated proteinproduction from the mutation bearing allele accounting for some of the most severe phenotypes in these genetic diseases.
Without the stop sign, viral transcription no longer follows the correct order, which has a negative impact on viral proteinproduction,” says Fang. “The virus hijacks this protein and makes it do something different than its normal job in cells. “We weren’t expecting to see this,” says Fang.
Point-of-care peptide hormone production enabled by cell-free protein synthesis. Marine biofilm engineered to produce current in response to smallmolecules. Peroxisomal metabolic coupling improves fatty alcohol production from sole methanol in yeast. DeWinter MA. ACS Synthetic Biology. ACS Synthetic Biology.
Read Programming inactive RNA-binding smallmolecules into bioactive degraders. Read Maximizing proteinproduction by keeping cells at optimal secretory stress levels using real-time control approaches. Molecular Therapy. Read Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.
Read Programming inactive RNA-binding smallmolecules into bioactive degraders. Read Maximizing proteinproduction by keeping cells at optimal secretory stress levels using real-time control approaches. Molecular Therapy. Read Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.
Imprinting disorders can also result from differences between parental genders in gene expression – that is, proteinproduction from the encoded information. We were able to show that (S)-PHA533533 had better uptake and that the same smallmolecule could be translated in human-derived neural cells, which is a huge finding.
Some examples of applications related to protein nitration assays Peroxynitrite and protein nitration In the application note Production of peroxynitrite by cancer-associated immune cells can be detected with a fluorescence-based assay researchers were able to detect peroxynitrite during phagocytosis using a smallmolecule sensor.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content